0001627223false00016272232024-05-212024-05-21

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

May 21, 2024

Date of Report (Date of Earliest Event Reported)

img172685009_0.jpg 

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

001-36794

 

46-4845564

(State or Other Jurisdiction

 

(Commission

 

(I.R.S. Employer

Of Incorporation)

 

File Number)

 

Identification No.)

 

1007 Market Street

Wilmington, Delaware 19801

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (302) 773-1000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Exchange on Which Registered

Common Stock ($0.01 par value)

 

CC

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

☐

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Chemours Company (the “Company”) held its annual meeting of shareholders on May 21, 2024 (the “Annual Meeting”).

At the Annual Meeting, shareholders:

•
elected all nine director nominees to serve a one-year term;
•
approved the Company’s annual “say-on-pay” vote on an advisory basis; and
•
ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm.

The final voting results for each proposal were as follows:

Proposal 1 – Election of Directors to Serve One-Year Term

 

Nominee

For

Against

Abstain

Broker Non-Votes

Curtis V. Anastasio

107,037,011 (93.8%)

7,108,377

230,686

16,051,105

Alister Cowan

110,687,093 (97.0%)

3,380,796

308,190

16,051,100

Mary B. Cranston

104,603,238 (91.6%)

9,551,712

221,133

16,051,096

Denise Dignam

110,820,826 (97.0%)

3,379,513

175,743

16,051,097

Dawn L. Farrell

109,748,954 (96.1%)

4,443,895

183,226

16,051,104

Pamela F. Fletcher

110,604,858 (97.0%)

3,459,155

312,065

16,051,101

Erin N. Kane

110,423,007 (96.7%)

3,730,068

223,002

16,051,102

Sean D. Keohane

108,173,264 (94.8%)

5,971,150

231,664

16,051,101

Guillaume Pepy

109,832,724 (96.2%)

4,311,317

232,036

16,051,102

 

 

Proposal 2 – Advisory Vote to Approve Named Executive Officer Compensation

 

For

Against

Abstain

Broker Non-Votes

108,041,241 (94.5%)

5,954,933

379,891

16,051,114

Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm

 

For

Against

Abstain

Broker Non-Votes

127,719,648 (97.9%)

2,491,323

216,208

n/a

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

THE CHEMOURS COMPANY

 

By:

 

/s/ Matthew S. Abbott

 

 

Matthew S. Abbott

 

 

Interim Chief Financial Officer

Date:

 

May 23, 2024

 

 

 

v3.24.1.1.u2
Document and Entity Information
May 21, 2024
Cover [Abstract]  
Entity Registrant Name Chemours Co
Amendment Flag false
Entity Central Index Key 0001627223
Document Type 8-K
Document Period End Date May 21, 2024
Entity Incorporation State Country Code DE
Entity File Number 001-36794
Entity Tax Identification Number 46-4845564
Entity Address, Address Line One 1007 Market Street
Entity Address, City or Town Wilmington
Entity Address, State or Province DE
Entity Address, Postal Zip Code 19801
City Area Code (302)
Local Phone Number 773-1000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Security 12b Title Common Stock ($0.01 par value)
Trading Symbol CC
Security Exchange Name NYSE
Entity Emerging Growth Company false
Grafico Azioni Chemours (NYSE:CC)
Storico
Da Ott 2024 a Nov 2024 Clicca qui per i Grafici di Chemours
Grafico Azioni Chemours (NYSE:CC)
Storico
Da Nov 2023 a Nov 2024 Clicca qui per i Grafici di Chemours